Europe Equine Healthcare Market (2025 - 2033) Size, Share & Trends Analysis Report By Product (Pharmaceuticals, Vaccine), By Indication (West Nile Virus, Tetanus), By Activity (Sports/Racing, Recreation), By Distribution Channel, By Country, And Segment Forecasts

Europe Equine Healthcare Market Summary

The Europe equine healthcare market size was estimated at USD 1.00 billion in 2024 and is projected to reach USD 1.90 billion by 2033, growing at a CAGR of 7.57% from 2025 to 2033. The market is witnessing growth driven by the growing equine population and economic value, rising veterinarian guidance for preventive care, and increasing adoption of insurance and welfare programs.

The growing equine population within countries such as Germany, France, and the UK is creating opportunities for advanced veterinary care for the development of pharmaceuticals, vaccines, diagnostics, or services. According to the European Commission report, the equine population in the European Union (EU) is estimated to be approximately 6 million, with 429,800 horses in the UK. This rising equine population is driving significant growth opportunities in Europe’s equine healthcare market, fostering innovation across pharmaceuticals, vaccines, diagnostics, and veterinary services.

Some of the countries in Europe, such as the UK, France, and Ireland, are continuously involved in horse breeding and recreational or sports activities. Hence, horses are of great economic value in the category of companion animals. Their high economic importance drives the market for larger investment in veterinary care, advanced therapeutics, and specialized hospital services. For instance, in March 2024, Scandinavian ChemoTech’s Animal Care secured a USD 52k order from Europe’s leading equine clinic, EquiTom (Belgium), adopting vetIQure TSE technology after successful sarcoid treatments, enhancing innovation and patient outcomes in equine healthcare. As a result, the need for efficient healthcare solutions, including pharmaceuticals, vaccines, diagnostic tools, and reproductive management products, continues to expand across European equine markets.

Rising veterinarian guidance for preventive care is one of the drivers of the European equine healthcare market. With increasing awareness of equine welfare, veterinarians are emphasizing regular check-ups, vaccinations, deworming, and nutritional management to reduce the incidence of costly diseases. Preventive protocols help owners maintain peak equine performance, minimize risks of infectious outbreaks, and improve long-term health outcomes. In Europe, structured veterinary programs and educational campaigns encourage horse owners to adopt proactive healthcare measures rather than reactive treatment. For instance, in November 2022, British Equestrian launched Equine Health Week with vet-led education, daily disease awareness and the release of new EIDAG (Equine Infectious Diseases Advisory Group) guidance to reduce equine infectious disease risks. In addition, in March 2023, CANTER, launched to combat equine antiparasitic resistance, uniting veterinarians, pharmaceutical companies, diagnostic providers, and policymakers to promote sustainable parasite control and safeguard horse health and welfare. This shift enhances animal well-being and fuels demand for vaccines, supplements, and diagnostic services, boosting the industry.

Insured owners are inclined to explore advanced diagnostics and treatments without worrying about the cost. The growing popularity of equine insurance in Europe is encouraging investment in veterinary care. As racehorses, sport horses, and breeding animals are widely insured in nations like the UK, France, and Sweden, owners are encouraged to choose expensive treatments and preventative measures. in addition, equine welfare programs are supported by both public and private entities in order to increase financial opportunities and industrial alliances. To improve knowledge of equine welfare, British racing, for example, published 10 free e-learning modules through Racing2Learn in September 2025. These modules were created in collaboration with veterinarians and covered topics such as health, behavior, heat stress, gastric ulcers, retraining, and lifetime racehorse care. Moreover, EU-backed welfare initiatives and national equine welfare charities actively promote responsible horse ownership, routine veterinary care, and early disease detection.

Market Concentration & Characteristics

The industry is moderately concentrated, with a mix of global leaders like Boehringer Ingelheim and Dechra holding significant shares, alongside regional players and specialized equine-focused firms. Large multinational companies dominate the pharmaceuticals and vaccines space due to strong R&D capabilities, while niche diagnostics, supplements, and service providers are more fragmented.

The industry is witnessing steady innovation, with advancements in vaccines, diagnostic tools, and digital platforms like telemedicine and wearable monitoring devices. Companies are increasingly focusing on preventive healthcare solutions, precision treatments, and sustainable products, addressing both horse welfare and environmental concerns. For instance, in June 2025, bioMérieux launched VETFIRE, a rapid PCR diagnostic kit for equine infectious respiratory diseases, delivering results in 20 minutes.

Mergers and acquisitions in the market remain moderate but strategic, as leading animal health companies seek to expand their product portfolios and strengthen their regional presence. Collaborations between pharmaceutical firms, diagnostic providers, and equine hospitals are driving the market. For instance, in February 2025, Horseware Ireland and EquiFit announced a strategic merger, uniting two leading equestrian brands to enhance innovation and deliver superior equestrian equipment.

Regulations are significantly transforming the European equine healthcare industry, especially concerning veterinary pharmaceuticals, welfare standards, and antiparasitic stewardship. Strict EU and national guidelines govern drug approvals, usage, and distribution. Regulations that focus on reducing antimicrobial resistance and promoting welfare-compliant practices have boosted preventive care among manufacturers to innovate within a stringent framework.

Horse owners are interested in holistic or chemical-free choices; the industry is under mild substitution pressure from alternative therapies, nutraceuticals, supplements, and natural medicines. Vaccines and medications are essential for treating and preventing disease, though. The market is witnessing growth in technologies such as digital monitoring, preventive care techniques, and nutritional treatments that are complementing alternatives, impacting demand patterns.

End-user concentration in the European equine healthcare industry is moderately high, with veterinarians, equine hospitals, and large training and breeding facilities dominating demand. Individual horse owners represent a large base, and institutional buyers such as racing stables, stud farms, and equestrian centers drive higher-value purchases. This concentration strengthens veterinary influence on purchasing decisions and shapes product adoption trends.

Product Insights

On the basis of products, pharmaceuticals held the largest revenue share of 25.71% in 2024, driven by the rising prevalence of infectious diseases, lameness, and parasitic infections among horses. According to the report of Equine Infectious Diseases Surveillance (EIDS), in January 2024, a novel variant of equine influenza virus was detected in the UK from a horse imported from Denmark. Increasing veterinary prescriptions, growing awareness about preventive care, and the development of advanced formulations, including anti-infectives, anti-parasitics, and pain management drugs, further strengthen demand. Innovation is exemplified such as by Boehringer Ingelheim’s approval of Aservo EquiHaler, the first licensed inhalant for severe equine asthma in February 2020. Moreover, equine owners’ focus on maintaining animal performance and welfare positions pharmaceuticals as the dominant growth engine within the regional market.

Software and services are anticipated to grow at the fastest CAGR over the forecast period, propelled by the digital transformation of veterinary practices and equine management. Increasing adoption of telemedicine, electronic health records, and wearable monitoring solutions enables real-time disease tracking, preventive care, and performance optimization. For instance, in October 2024, Zomedica expanded its European distribution partnership with Grovet, granting exclusive rights for PulseVet and TRUFORMA platforms across Italy and the UK, enhancing equine diagnostic and therapeutic reach. The expansion of this market is further accelerated by the growing need for data-driven decision-making, effective resource management, and customized healthcare solutions.

Indication Insights

On the basis of indication, parasitic infections dominated the market with the largest revenue share of 27.4% in 2024, driven by their high prevalence and notable effects on the performance and health of horses. There is a constant need for antiparasitic medications and diagnostic equipment since common parasites like strongyles, tapeworms, and bots require ongoing care and observation. Preventive veterinary advice, industry-wide efforts to fight anthelmintic resistance, and growing horse owner awareness all help to maintain market dominance and establish parasite treatment as a crucial area of equine healthcare that generates income.

Equine Herpes Virus (EHV) is anticipated to grow at the fastest CAGR over the forecast period, due to its rising prevalence and the serious health and financial effects it has on horse populations. According to the EIDS report, EHV-1 disease was reported in France, Germany, the Netherlands, and Sweden with 3, 5, 6 and 5 outbreaks in the first quarter of 2024. EHV can cause respiratory sickness, neurological abnormalities, and abortion in pregnant mares, horse owners, and trainers; thus, veterinary professionals are becoming more aware of the virus and taking preventative measures. The development of better antiviral treatments, increased vaccination uptake, and sophisticated diagnostic technologies for early detection are the main drivers of the expansion.

Activity Insights

On the basis of activity, the sports and racing segment held the largest revenue share of over 55% in 2024, driven by the economic importance of racing, show jumping, and competitive equestrian sports. High-value horses require advanced healthcare solutions, including diagnostics, preventive care, injury management, and performance optimization, fueling consistent demand. Increasing investments by owners, specialized veterinary softwares, and health tracking systems further strengthen this segment’s dominance. For instance, in August 2025, Garmin introduced the Blaze equine wellness system, a tail wrap with advanced sensors enabling riders, owners, and trainers to monitor horse health and fitness, supporting informed decisions for training, performance, and overall well-being.

The recreation segment is anticipated to grow at the fastest CAGR over the forecast period, driven by the increasing popularity of leisure riding, equestrian tourism, and horse ownership for companionship. Rising disposable incomes and lifestyle changes are encouraging more individuals to pursue recreational equine activities, driving demand for preventive healthcare, supplements, and grooming products. Moreover, veterinary services, wellness programs, and innovative equine care solutions are expanding to meet the needs of recreational horse owners, positioning this segment as a dynamic growth driver.

Distribution Channel Insights

On the basis of distribution channel, veterinary hospitals and clinics accounted for the largest revenue share of 43.95% in 2024, driven by their critical role in providing specialized care, diagnostics, surgeries, and preventive treatments. The growing prevalence of equine diseases, rising sports and recreational horse populations, and increasing owner awareness of advanced medical services are propelling the demand. Equipped with the latest facilities, skilled veterinarians, and advanced technologies, these establishments serve as the foundation of equine health in Europe by providing comprehensive healthcare solutions, ranging from simple examinations to intricate operations.

The e-commerce segment is anticipated to grow at the fastest CAGR over the forecast period, due to the growing use of internet platforms and the need for easy access to healthcare treatments, supplements, and veterinary supplies. Online shopping has gained momentum and is popular among horse owners due to the cost savings, product variety, and doorstep delivery. This tendency is further supported by rising expenditures in digital infrastructure, the growth of online veterinary pharmacies, and customized subscription models. E-commerce has been reaffirmed as a pivotal growth engine in horse healthcare due to the pandemic-induced shift to online channels.

Country Insights

Germany Equine Healthcare Market Trends

Germany equine healthcare market held a revenue share of 20.27% in 2024, due to the growing need for preventative healthcare, sophisticated equestrian sports, and increased horse ownership. The veterinary care industry is expanding thanks to major players like Boehringer Ingelheim, Zoetis, Ceva, and MSD Animal Health, as well as diagnostic innovators like bioMérieux. Strategic developments, such as in July 2025, Compagnie Nationale à Portefeuille’s partnered with Equine Care Group, highlighting international investment and collaborative expansion.

Key Europe Equine Healthcare Companies Insights

Key players operating in the Europe equine healthcare market are undertaking various initiatives to strengthen their presence and increase the reach of their products and services. Strategies such as expansion activities and partnerships are key in propelling the market growth.

Recent Developments

• In February 2025, Aznalcóllar Equine Hospital partnered with Equine Care Group for veterinary leadership and advancing equine healthcare across the Iberian Peninsula.

• In October 2024, MYOS CORP launched Equine Muscle Formula, enhancing Fortetropin’s proven palatability and safety in horses. This marks MYOS’s strategic entry into the equine nutrition market, targeting muscle health and performance enhancement.

• In March 2024, Scandinavian ChemoTech’s Animal Care secured a USD 52k order from EquiTom, Europe’s largest equine clinic, integrating vetIQure TSE technology for advanced sarcoid treatment, reinforcing innovation and value in equine cancer therapies.

Europe Equine Healthcare Market Report Scope

Europe Equine Healthcare Market Report Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Europe equine healthcare market report based on product, indication, activity, distribution channel, and country:

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Pharmaceuticals

    • Parasiticides

    • Anti-infectives

    • Anti-inflammatory & Analgesics

    • Other Pharmaceuticals

  • Vaccines

  • Medicinal Feed Additives

  • Orthobiologics

  • Diagnostics

    • Diagnostic Test Kits

    • Diagnostics Equipment

  • Software & Services

    • Practice Management Software

    • Imaging Software

    • Telehealth Software

    • Other Software & Services

  • Others

• Indication Outlook (Revenue, USD Million, 2021 - 2033)

  • Musculoskeletal Disorders

  • Parasitic Infections

  • Equine Herpes Virus

  • Equine Viral Arteritis (EVA)

  • Equine Influenza

  • West Nile Virus

  • Tetanus

  • Other Indications

• Activity Outlook (Revenue, USD Million, 2021 - 2033)

  • Sports/ Racing

  • Recreation

  • Other Activities

• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)

  • Veterinary Hospitals & Clinics

  • E-commerce

  • Equestrian Facilities

  • Other Channels

• Country Outlook (Revenue, USD Million, 2021 - 2033)

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Sweden

  • Norway

  • Denmark

  • Netherlands

  • Russia

  • Switzerland